61
Participants
Start Date
March 31, 2007
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Sunitinib Malate
50 mg by mouth daily for 4 weeks, then 2 weeks off.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Pfizer
INDUSTRY
M.D. Anderson Cancer Center
OTHER